MyBioSource
Private Company
Funding information not available
Overview
MyBioSource is a well-established, privately-held reagent company that has operated for nearly two decades, positioning itself as a reliable supplier in the highly fragmented life science research tools market. The company's business model is based on the production, curation, and distribution of essential consumables, generating revenue through direct sales to end-users and distributors. Its value proposition centers on offering a vast catalog of products with a focus on accessibility and customer service, though it operates in a highly competitive landscape dominated by larger players. As a private entity, its financial performance and strategic initiatives are not publicly disclosed, requiring inference from its market position and industry trends.
Technology Platform
Integrated supply chain and product development for life science reagents, including antibody production/sourcing, assay kit development, and bioinformatic catalog management.
Opportunities
Risk Factors
Competitive Landscape
The market is highly fragmented but dominated by giants like Thermo Fisher Scientific, Abcam (Danaher), and Merck Millipore. MyBioSource competes in the mid-tier/value segment against other specialized antibody suppliers and distributors, where competition is based on price, catalog breadth, and customer service rather than proprietary technology.